These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 19098393

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Will children with cancer benefit from the new European Paediatric Medicines Regulation?
    Vassal G.
    Eur J Cancer; 2009 Jun; 45(9):1535-46. PubMed ID: 19419857
    [Abstract] [Full Text] [Related]

  • 43. Review: new biological insights in early clinical studies.
    Maur M, Sessa C.
    Hematol Oncol; 2007 Jun; 25(2):53-7. PubMed ID: 17351979
    [Abstract] [Full Text] [Related]

  • 44. Ligand-based targeted therapy for cancer tissue.
    Das M, Mohanty C, Sahoo SK.
    Expert Opin Drug Deliv; 2009 Mar; 6(3):285-304. PubMed ID: 19327045
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. [Current problems in development of new anticancer agents for new molecular targets].
    Nishii K.
    Gan To Kagaku Ryoho; 1996 Jan; 23(2):211-8. PubMed ID: 8611049
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. The interplay of structural information and functional studies in kinase drug design: insights from BCR-Abl.
    Eck MJ, Manley PW.
    Curr Opin Cell Biol; 2009 Apr; 21(2):288-95. PubMed ID: 19217274
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Design and conduct of phase II studies of targeted anticancer therapy: recommendations from the task force on methodology for the development of innovative cancer therapies (MDICT).
    Booth CM, Calvert AH, Giaccone G, Lobbezoo MW, Eisenhauer EA, Seymour LK.
    Eur J Cancer; 2008 Jan; 44(1):25-9. PubMed ID: 17845846
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Successes and challenges in translational research: the development of targeted therapy for gastrointestinal stromal tumours.
    Renouf DJ, Wilson L, Blanke CD.
    Clin Cancer Res; 2009 Jun 15; 15(12):3908-11. PubMed ID: 19509180
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Shortcomings of current therapies for non-small-cell lung cancer: unmet medical needs.
    Burris HA.
    Oncogene; 2009 Aug 15; 28 Suppl 1():S4-13. PubMed ID: 19680296
    [Abstract] [Full Text] [Related]

  • 60. Molecular biology and anticancer drug discovery.
    Lazo JS.
    Prog Mol Biol Transl Sci; 2010 Aug 15; 95():9-29. PubMed ID: 21075327
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.